Top tweets on neurology in December 2019
1. David Perlmutter’s tweet on meditation
David Perlmutter, a neurologist, tweeted on the benefits of meditation. He noted that meditation helps in increased connectivity to prefrontal cortex, improves relationships and memory, and reduces stress.
He noted that meditation can also improve creativity as well as sleep while providing better decision making ability.
Benefits of meditation:
1) Increased connectivity to prefrontal cortex
2) Better decision-making ability
3) Improved relationships
4) Better memory
5) Reduced inflammation
6) Reduced stress
7) Improved creativity
8) Improved sleep
9) Greater concern for the health of the planet
— David Perlmutter, MD (@DavidPerlmutter) December 26, 2019
Username: David Perlmutter, MD
Twitter handle: @DavidPerlmutter
2. Eric Topol’s tweet on risk of introducing AI into healthcare
Eric Topol, a physician and scientist, shared an article on the risks associated with introducing health products powered by artificial intelligence, such as virtual doctors, wearable sensors and chatbots.
The influencer noted that AI systems do not go through rigorous testing similar to that of medical devices and have been known to make mistakes. AI systems developed in one hospital often fail when deployed in another. They are also known to discriminate against minorities, the article added.
— Eric Topol (@EricTopol) December 24, 2019
Username: Eric Topol
Twitter handle: @EricTopol
3. Dr David Nicholl’s tweet on US-UK trade deal
Among neurology tweets, Dr David Nicholl, a neurologist, drew attention to a tweet about US-UK trade in pharmaceuticals. A trade deal between the UK and the US after Brexit is expected to cost millions of dollars to the National Health Service (NHS).
Post-Brexit, cost of vital drugs for indications such as Crohn’s disease and rheumatoid arthritis is expected to dramatically increase.
This thread needs a significant number of reads than the pathetic number so far, to realise that this is absolutely about economics not privatisation👇 to understand US-UK trade in pharmaceuticals #teamnicholl the extra costs to the NHS are up to £500M/week put that on a bus😡 https://t.co/lXC5pDvLnr
— Dr David '#VaccinePlus 😷' Nicholl (@djnicholl) December 3, 2019
Username: Dr David Nicholl
Twitter handle: @djnicholl
4. Vaughan Bell’s tweet on Alzheimer’s ‘cabal’
Vaughan Bell, a neuropsychologist, shared an article on how a faction of scientists or cabal thwarted alternative approaches to the development of treatments for Alzheimer’s. This faction controlled what research papers were published and which scientists got funding.
The findings were reported from interviews conducted with more than two dozen scientists who adopted an alternate approach to the development of treatments for Alzheimer’s. The article noted that the influence used by the cabal might have been responsible for the delay in the development of a treatment for Alzheimer’s.
The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades https://t.co/nTsZtuKXo1 Important piece with wider implications about institutionalised group think in science – via @stuartbuck1
— Vaughan Bell (@vaughanbell) December 28, 2019
Username: Vaughan Bell
Twitter handle: @vaughanbell
5. Prof Michael Hanna’s tweet on lecture by professors Sarah Tabrizi & Gill Bates
Prof Michael Hanna, a neurologist and director at the UCL Queen Square Institute of Neurology, tweeted on how proud he was of two professors from the institute, Sarah Tabrizi and Gill Bates, for delivering the Jean Shanks Lecture at the Academy of Medical Sciences. The Jean Shanks Lecture is named after the Dr Jean Shanks who established the Jean Shanks Foundation and contributed to medical science.
Professors Sarah Tabrizi and Gill Bates delivered a lecture on new therapies for Huntington’s disease at the annual event held in November.
Very proud of UCL Queen Square Institute Neurology Profs Sarah Tabrizi & Gill Bates now giving academy Jean Shanks lecture: spectacular progress towards therapy in Huntington’s – antisense start of a new therapy era led from Queen Square @UCLIoN @UCLBrainScience @acmedsci @uclh pic.twitter.com/zL2b7rqrly
— Prof Michael Hanna (@MikeHanna18) December 3, 2019
Username: Prof Michael Hanna
Twitter handle: @MikeHanna18
6. Mark Baxter’s tweet on new Alzheimer’s study
Mark Baxter, a neuroscientist, tweeted on a new study of a rhesus monkey model performed to understand early Alzheimer’s pathogenesis. The study showed that oligomeric of the amyloid beta peptide in the monkey brain impacts synaptic integrity and induces accelerated cortical aging.
The results indicate that monkeys can be used as a platform to understand age-related vulnerabilities of the primate brain. It may also develop disease-modifying therapies for the treatment of AD and related dementias.
Username: Mark Baxter #ITMFA
Twitter handle: @markgbaxter
7. GrowingUpAutistic’s tweet on working with disabled customers
GrowingUpAutistic, an autistic adult, tweeted about being offered to work in specific shifts at her workplace that focus on ideas that support disabled costumers. She further noted that while growing up she was told that autism would be her disadvantage in her work life but it turned out to be her strength.
I work in retail & the other day my manager asked me whether I would like specific shifts. These shifts will primarily focus on my ideas towards supporting disabled costumers. Growing up I was told #Autism would be my disadvantage in working life but it’s actually my strength!.
— GrowingUpAutistic (@LibbyAutism) December 7, 2019
Twitter handle: @LibbyAutism
8. Rosemarie CarreiroÂû’s tweet on placing her son in a group home
Rosemarie CarreiroÂû, a mental health advocate, tweeted about the apathy shown by people towards autistic children. She noted that people consider her crazy when she states that her autistic son will not go into a group home unless he wants to.
She further noted that being autistic does not mean that her son does not have a say in his life.
I hate when I state that I will NOT place my son in a group home ever UNLESS he says he wants to go and people look at me like I am "crazy".
Just because he is #autistic does NOT mean he doesn't have a say in his life …it's HIS life.#ActuallyAutistic
— Rosemarie Carreiro Âû (@RoseMCarreiro) December 11, 2019
Username: Rosemarie CarreiroÂû
Twitter handle: @RoseMCarreiro
9. Mark Weatherall’s tweet on getting erenumab approved for use on the NHS
Mark Weatherall, a neurologist, tweeted on trying to get erenumab approved for use on the National Health Service (NHS) in Wales and England. Erenumab, also known as Aimovig, is used for the treatment of migraine. The drug was rejected for use by the NHS in September 2016 noting that there was uncertainty regarding its clinical and cost effectiveness.
Mark noted that he along with his colleagues will be arguing against the original assessment and that it should be reviewed.
We few, we happy few… off to storm the breach at @NICEComms to try to get #erenumab approved for use on the NHS in England and Wales. @petergoadsby @IIHDrBirmingham and I will argue that the original assessment was flawed and should be revised. Updates will follow…
— Mark Weatherall (@weatherallmw) December 4, 2019
Username: Mark Weatherall
Twitter handle: @weatherallmw
10. Vaughan Bell’s tweet on the Welcome Trust’s commitment to mental health
Vaughan Bell tweeted on the launch of a five-year, £200m ($222.7m) commitment towards research on mental health by the Welcome Trust, a research charity based in London, UK. The research will focus on understanding, preventing and treating anxiety and depression in young people.
The @wellcometrust launch a five-year, £200 million commitment to mental health research https://t.co/iRHzy1YstQ focused on understanding, funding, preventing and treating anxiety and depression in young people – via @mirandarwolpert
— Vaughan Bell (@vaughanbell) December 18, 2019
Username: Vaughan Bell
Twitter handle: @vaughanbell